Intellia Therapeutics, Inc. operates as a clinical-stage genome editing company focused on developing potentially curative therapeutics using CRISPR/Cas9-based technologies. The company offers clustered, regularly interspaced short palindro...
Leadership
John M. Leonard M.D.
President, CEO & Director
Edward J. Dulac III
Executive VP, CFO & Treasurer
Birgit Schultes Ph.D.
Executive VP & Chief Scientific Officer
James E. Basta Esq., J.D.
Executive VP, General Counsel & Corporate Secretary
